Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3055941000168118 | Praxbind (idarucizumab 2.5 g / 50 mL) injection, 2 x 50 mL vials (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3055951000168116 | Praxbind 2.5 g/50 mL injection, 2 x 50 mL vials | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Praxbind (idarucizumab 2.5 g / 50 mL) injection, 2 x 50 mL vials (trade product pack) | Is a | trade product pack | true | Inferred relationship | Some | ||
| Praxbind (idarucizumab 2.5 g / 50 mL) injection, 2 x 50 mL vials (trade product pack) | Is a | idarucizumab 2.5 g/50 mL injection, 2 x 50 mL vials | true | Inferred relationship | Some | ||
| Praxbind (idarucizumab 2.5 g / 50 mL) injection, 2 x 50 mL vials (trade product pack) | has TPUU | Praxbind 2.5 g/50 mL injection, 50 mL vial | true | Inferred relationship | Some | 1 | |
| Praxbind (idarucizumab 2.5 g / 50 mL) injection, 2 x 50 mL vials (trade product pack) | has TP | Praxbind | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Praxbind 2.5 g/50 mL injection, 2 x 50 mL vials | Is a | True | Praxbind (idarucizumab 2.5 g / 50 mL) injection, 2 x 50 mL vials (trade product pack) | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR